Patient and Payer Education: Overcoming Hesitancy and Establishing Trust to Maximize the Commercial Potential of Biosimilars
The Biosimilars Market Global Outlook is highly positive, based on the universal need to control healthcare costs and the increasing regulatory acceptance of the comparability concept. While the initial regulatory pathways were established independently by leading bodies (like the US FDA and European Medicines Agency), there is a strong global trend toward harmonization of requirements, which...
0 Commenti 0 condivisioni 500 Views 0 Anteprima